Renovorx, INC. (RNXT) — 8-K Filings

8-K Filings (18)

• RenovoRx Files 8-K: Officer/Director Changes & Exhibits — Mar 27, 2026 Risk: medium
  RenovoRx, Inc. filed an 8-K on March 27, 2026, reporting changes under Item 5.02 concerning the departure of directors or officers, election of directors, appoi
• 8-K Filing — Nov 14, 2025
• RenovoRx Files 8-K on Shareholder Vote — Jun 25, 2025 Risk: medium
  RenovoRx, Inc. filed an 8-K on June 25, 2025, reporting on a shareholder vote. The filing indicates that the company held a meeting where security holders were
• RenovoRx, Inc. Files 8-K for Material Agreement — Feb 10, 2025 Risk: medium
  RenovoRx, Inc. announced on February 10, 2025, that it entered into a Material Definitive Agreement on February 6, 2025. The filing also includes other events a
• RenovoRx Files 8-K on Financials — Nov 14, 2024 Risk: medium
  RenovoRx, Inc. filed an 8-K on November 14, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and e
• RenovoRx Files 8-K: Procedural Update — Sep 25, 2024 Risk: low
  RenovoRx, Inc. filed an 8-K on September 25, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific financ
• RenovoRx Dismisses Auditor BDO USA, LLP — Aug 16, 2024 Risk: medium
  RenovoRx, Inc. announced on August 16, 2024, that it has dismissed its principal independent registered public accounting firm, BDO USA, LLP, effective August 1
• RenovoRx Appoints Dr. Jonathan Lim to Board — Jun 7, 2024 Risk: medium
  RenovoRx, Inc. announced on June 7, 2024, that its Board of Directors has appointed Dr. Jonathan Lim as a new director, effective immediately. Dr. Lim brings ex
• RenovoRx Changes Auditors — May 3, 2024 Risk: medium
  RenovoRx, Inc. announced on May 3, 2024, that their independent registered public accounting firm, WithumSmith+Brown, PC, has resigned. The company is in the pr
• RenovoRx Prices $1.5M Registered Direct Offering — Apr 18, 2024 Risk: medium
  RenovoRx, Inc. announced on April 18, 2024, that it entered into a securities purchase agreement on April 17, 2024, to sell approximately $1.5 million of its co
• RenovoRx, Inc. Files 8-K Report — Apr 16, 2024 Risk: medium
  On April 16, 2024, RenovoRx, Inc. filed an 8-K report detailing an "Other Event." The filing does not provide specific details about the event itself, but it in
• RenovoRx Sells $1M in Stock — Apr 15, 2024 Risk: medium
  On April 15, 2024, RenovoRx, Inc. filed an 8-K detailing an unregistered sale of equity securities. The company entered into a Securities Purchase Agreement on
• RenovoRx, Inc. Files 8-K: Material Agreement & Other Events — Apr 9, 2024 Risk: medium
  On April 9, 2024, RenovoRx, Inc. reported the entry into a material definitive agreement. The company also disclosed other events and filed financial statements
• RenovoRx Appoints Biotech Veteran Rothberg to Board — Mar 14, 2024 Risk: medium
  RenovoRx, Inc. announced on March 14, 2024, a change in its board of directors. Specifically, Dr. Jonathan M. Rothberg has been appointed to the Board of Direct
• RenovoRx Faces Nasdaq Delisting, Appoints New CEO — Feb 23, 2024 Risk: high
  RenovoRx, Inc. received a delisting notice from Nasdaq on February 16, 2024, due to its common stock closing below the minimum bid price of $1.00 for 30 consecu
• RenovoRx Director James Ahlers Resigns from Board, Committees — Feb 9, 2024 Risk: low
  RenovoRx, Inc. announced on February 9, 2024, that James Ahlers resigned from its Board of Directors, effective February 5, 2024. Ahlers, who also served on the
• RenovoRx Files 8-K: Material Agreement & Officer Compensation Changes — Jan 29, 2024
  RenovoRx, Inc. filed an 8-K on January 29, 2024, reporting a material definitive agreement and changes in compensatory arrangements for certain officers, with t
• RenovoRx Opts Out of EGC Accounting Transition Period — Jan 2, 2024
  RenovoRx, Inc. filed an 8-K on January 2, 2024, reporting an event that occurred on December 26, 2023. This filing indicates that the company is an 'emerging gr

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX